Market open
OptiNose/$OPTN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About OptiNose
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
Ticker
$OPTN
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
132
Website
OptiNose Metrics
BasicAdvanced
$116M
Market cap
-
P/E ratio
-$0.35
EPS
-0.12
Beta
-
Dividend rate
Price and volume
Market cap
$116M
Beta
-0.12
52-week high
$2.10
52-week low
$0.65
Average daily volume
261K
Financial strength
Current ratio
3.943
Quick ratio
3.43
Long term debt to equity
-295.487
Total debt to equity
-297.505
Interest coverage (TTM)
-0.94%
Management effectiveness
Return on assets (TTM)
-9.89%
Return on equity (TTM)
72.72%
Valuation
Price to revenue (TTM)
1.243
Price to book
-2.69
Price to tangible book (TTM)
-2.69
Price to free cash flow (TTM)
-2.626
Growth
Revenue change (TTM)
3.91%
Earnings per share change (TTM)
-25.60%
3-year revenue growth (CAGR)
6.52%
3-year earnings per share growth (CAGR)
-42.45%
What the Analysts think about OptiNose
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for OptiNose stock.
OptiNose Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OptiNose Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OptiNose News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OptiNose stock?
OptiNose (OPTN) has a market cap of $116M as of November 08, 2024.
What is the P/E ratio for OptiNose stock?
The price to earnings (P/E) ratio for OptiNose (OPTN) stock is 0 as of November 08, 2024.
Does OptiNose stock pay dividends?
No, OptiNose (OPTN) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next OptiNose dividend payment date?
OptiNose (OPTN) stock does not pay dividends to its shareholders.
What is the beta indicator for OptiNose?
OptiNose (OPTN) has a beta rating of -0.12. This means that it has an inverse relation to market volatility.